GlassScriptPhysician profile
Paul A Smurda
NPI 1053416511
$29,319.30
in general payments reported to CMS, 2019-2025
32 companies · $518 in 2025
The $518 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $131 · 2021: $256 · 2022: $370 · 2023: $535 · 2024: $429 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.80 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,612.11 | 2019 | |
| Abbvie INC. | $619.11 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $469.63 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $268.06 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $163.94 | 2019-2025 | |
| Pfizer INC. | $157.65 | 2019-2024 | |
| Shield Therapeutics INC | $118.67 | 2024-2025 | |
| Kvk-Tech, INC. | $106.61 | 2019 | |
| Novo Nordisk INC | $92.62 | 2019-2025 | Wegovy |
| Hologic Sales and Service, LLC | $75.12 | 2022-2024 | Aptima, Acessa Provu System |
| Millicent US INC | $65.18 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Coopersurgical, INC. | $64.42 | 2019 | |
| Amgen INC. | $48.43 | 2020-2025 | Otezla, Repatha |
| Exeltis, USA INC. | $48.14 | 2022 | |
| Optumhealth Care Solutions, LLC | $46.67 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.22 | 2019-2024 | Xifaxan |
| Monaghan Medical Corporation | $29.13 | 2024 | Aerobika |
| Allergan, INC. | $28.99 | 2019 | |
| Daiichi Sankyo INC. | $26.50 | 2023 | Injectafer |
| Lupin INC. | $25.98 | 2019-2020 | |
| Agile Therapeutics, INC. | $24.93 | 2022 | |
| Organon LLC | $22.47 | 2023 | Nexplanon |
| Cgg Medical INC | $21.79 | 2025 | |
| Northgate Technologies, INC. | $21.00 | 2024 | Stimsite |
| Eisai INC. | $20.34 | 2021 | |
| Boston Scientific Corporation | $17.63 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.04 | 2022 | |
| Lilly USA, LLC | $13.99 | 2024 | Zepbound |
| Dysis Medical, INC. | $13.84 | 2022 | |
| Minerva Surgical, INC | $13.50 | 2020 | |
| Myovant Sciences INC. | $12.71 | 2021 | |
| Avion Pharmaceuticals | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Smurda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.